June 27, 2024 Texas Chapter Drug Diversion Conference

Details Price Qty
Pre-Approved Collin College Law Enforcement Academyshow details + $0.00 (USD)  
General Registrationshow details + $100.00 (USD)  
Law Enforcement/State Regulatory/Militaryshow details + $75.00 (USD)  
NADDI Board Membershow details + $0.00 (USD)  
NADDI Corporate Membershow details + $0.00 (USD)  
Speakershow details + $0.00 (USD)  

  • 2024 Texas Chapter Conference
     June 27, 2024
     8:00 am - 5:00 pm

Mark your calendars for our upcoming state chapter conference, focusing on drug diversion,  the opioid crisis and more!

June 27, 2024
NADDI Texas Chapter Conference

Hosted at Collin College – Law Enforcement Academy
2200 W. University Dr.
McKinney, TX 75069

This event caters to healthcare and law enforcement experts, focusing on the issues of prescription drug diversion, investigative practices, and the shifting trends in drug usage.

This educational session provides 2 hours of Continuing Professional/Medical Education accredited by AMA, ACPT, AAPA, and ADA. Presentations will be delivered by professionals from both law enforcement and healthcare sectors, addressing the dynamic
nature of drug-related challenges and emphasizing the significance of collaborative efforts in combating drug diversion.

*You do not have to be a member to attend but you must qualify for NADDI membership to attend NADDI conferences. All attendees receive a complimentary one year membership. Current members receive an additional one year membership.

Thursday, June 27th, 2024

7:30 – 8:00 am
Conference Registration

8:00 – 8:30 am
Welcome and Opening Remarks
William JC Matthews, NADDI Texas State Chapter President

8:30 – 9:30 am
Fentanyl-Beginning to Now

Summary: The evolution of fentanyl from a potent analgesic used in hospitals to a deadly drug sold on the street. This presentation will cover the facts and abuse of synthetic opioid fentanyl.

9:30 – 10:30 am
Addressing Drug Diversion in Emergency Medical Systems

Joe Schmider
Texas EMS Director at Texas Department of State Health Services

Summary: This is a discussion about the risks associated with drug diversion, such as patient harm and legal consequences, as well as methods for detecting and preventing diversion within EMS organizations. The presentation also explores best practices for medication inventory management, staff training on diversion prevention, and implementing safeguards such as medication tracking systems. Additionally, it discusses the importance of creating a culture of accountability and transparency within EMS teams to effectively address and mitigate drug diversion issues.

 10:30 – 10:45am

10:45 – 11:45 pm
Healthcare Drug Diversion Trends

Aimee Posivak, Director of Controlled Substance Utilization and
Diversion Prevention for Tenet Health

Summary: An in-depth view of drug diversion, examining it through the perspectives of healthcare executives, pharmacy professionals, and specialists in drug diversion. This presentation will highlight the challenges, and discuss the vital role of collaborative efforts between healthcare and law enforcement.

12:00 – 1:00 pm
Networking Luncheon

1:00 – 3:00 pm
Red Flags
(2 hours CME from AMA, ACPE, AAPA, and ADA)

William JC Matthews or Susannah Herkert, Guidepost

Summary: This course offers trainees an overview of red flags indicating the diversion of controlled substances, along with an exploration of the GUIDE compliance model. Attendees will receive detailed guidance on controlled substance compliance through step-by-step explanations. Learning objectives include defining “red flag,” identifying common red flags for diversion, understanding the consequences of ignoring red flags, and exploring solutions to address them.

3:00 pm – 3:15 pm

3:15 – 4:15 pm
DEA Unveiled: Exploring Drug Enforcement Administration’s Role and Clarifying Common Misconceptions
Lisa Sullivan
Retired DEA Diversion Program Manager

Summary: This presentation provides an in-depth examination of the DEA regulation and registration processes within the context of preventing drug diversion in various healthcare settings. Attendees will gain a comprehensive understanding of what to expect when DEA arrives for inspections, audits, or investigations. By exploring DEA’s regulatory framework, attendees will learn crucial strategies and best practices for maintaining compliance and safeguarding against diversion risks. Additionally, the presentation will highlight proactive measures healthcare facilities can implement to align with DEA requirements, enhance accountability, and foster a culture of integrity and safety.

4:15 – 4:45 pm
Empowering Community Leaders: Opioid Overdose Recognition and Naloxone Administration

Aimee Posivak, Director of Controlled Substance Utilization and
Diversion Prevention for Tenet Health

 Summary: Naloxone (Narcan) is a life-saving medication that can reverse an overdose from opioid- including heroin, fentanyl, and prescription opioid medications- when administered in time. This discussion will highlight when and how to use naloxone. Every participant will be provided with instructions on how to acquire complementary naloxone. 

4:45-5:00 pm
Closing Remarks


Refund Policy

All registrations are subject to NADDI’s Registration Deadline and Refund Policy.


Venue Website:

2200 W. University Drive, McKinney, Texas, 75069, United States

National Association of Drug Diversion Investigators Federal Tax ID: 52-1660752 / DUNS Number: 073539913

Copyright © 2024 - NADDI. All Rights Reserved. Privacy Policy / Trademark Policy / Copyright Policy / Refund Policy

Log in with your credentials


Forgot your details?

Create Account